Clinical Trial Update: Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating fusidic acid 1% for bacterial conjunctivitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Fusidic Acid 1% (fusidic acid)

Snippet

Sponsor: Baxis Pharmaceuticals, Inc. | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: RECRUITING